Denali Therapeutics (DNLI) FCF Margin Growth (3y) (2021 - 2023)
Denali Therapeutics (DNLI) FCF Margin Growth (3y) (2021 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Denali Therapeutics |
4.02 Bn |
4.02 Bn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
2.92 Mn |
| Jun 30, 2023 |
68,718.00 |
| Mar 31, 2023 |
10.63 Mn |
| Sep 30, 2022 |
8.97 Mn |
| Jun 30, 2022 |
5.44 Mn |
| Mar 31, 2022 |
58,705.00 |
| Dec 31, 2021 |
-66,257.00 |
| Sep 30, 2021 |
204,406.00 |
| Jun 30, 2021 |
220,957.00 |
| Mar 31, 2021 |
-502.92 Mn |
